PAR5 COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRATM) IN THE TREATMENT OF US PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
May 1, 2004, 00:00
10.1016/S1098-3015(10)62129-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)62129-8/fulltext
Title :
PAR5 COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRATM) IN THE TREATMENT OF US PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62129-8&doi=10.1016/S1098-3015(10)62129-8
First page :
Section Title :
Open access? :
No
Section Order :
67